It seems really odd to me that Biogen has now had two of their drugs, Tysarbi and Rituxin, linked to PML and they just recently happened to buy a company researching PML.
Who wants to be a lab rat for their next product? Not me.


gwa
The name of the company is Alnylam Pharmaceuticals Inc. of Cambridge.gwa wrote:Biogen recently purchased a biotech company that was doing research on PML. I think I read about this here, but cannot find the name of the company.
And some people wonder why I don't trust BiogenIt seems really odd to me that Biogen has now had two of their drugs, Tysarbi and Rituxin, linked to PML and they just recently happened to buy a company researching PML.
Who wants to be a lab rat for their next product? Not me.
![]()
![]()
gwa
PMFJI but the autoimmune theory, which has been the absolute main focus of the MS research community for decades, has brought us what results? Add this to the exclusive EAE mouse and after all this time we have neither a cause and certainly nothing remotely close to a cure.Wonderfulworld wrote:I think the risks of PML are too high/too unknown for me to dabble just yet.......but if the MS ups the stakes (not an invitation) I could get desperate enough.
But if it's not autoimmune Chris, what is it? Curious to hear...........